Spots Global Cancer Trial Database for mitomycin c
Every month we try and update this database with for mitomycin c cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study | NCT02793128 | Carcinoma, Tran... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma | NCT03658304 | Urothelial Carc... | Mitomycin c | 18 Years - 99 Years | University of Florida | |
| uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto | NCT05874921 | Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Canc... Urothelial Carc... Carcinoma, Tran... Transitional Ce... | Jelmyto (mitomy... | 18 Years - | UroGen Pharma Ltd. | |
| Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia | NCT00003003 | Leukemia | sargramostim mitomycin C mitoxantrone hy... | 18 Years - 120 Years | Dartmouth-Hitchcock Medical Center | |
| Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma | NCT03658304 | Urothelial Carc... | Mitomycin c | 18 Years - 99 Years | University of Florida | |
| Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUC | NCT05731622 | Upper Urinary T... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | ||
| Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | NCT00005870 | Pancreatic Canc... | fluorouracil gemcitabine hyd... mitomycin C rubitecan | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00024349 | Bladder Cancer | fluorouracil mitomycin C radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors | NCT00003710 | Unspecified Adu... | irinotecan hydr... mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors. | NCT01705002 | Cancer Solid Tumor Metastatic Colo... | Promitil Capecitabine Bevacizumab | 18 Years - 80 Years | Lipomedix Pharmaceuticals Inc. | |
| Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003240 | Lung Cancer | cisplatin ifosfamide mitomycin C vinblastine sul... vindesine vinorelbine tar... conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | NCT00005870 | Pancreatic Canc... | fluorouracil gemcitabine hyd... mitomycin C rubitecan | 18 Years - | National Cancer Institute (NCI) | |
| A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer | NCT00192049 | Superficial Bla... | Gemcitabine mitomycin C | 18 Years - | Eli Lilly and Company | |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | NCT00024349 | Bladder Cancer | fluorouracil mitomycin C radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | NCT02040142 | Peritoneal Carc... Colorectal Canc... Appendiceal Can... Peritoneal Meso... Pseudomyxoma Pe... Gastric Cancer | HIPEC Mitomycin C | 18 Years - | Albert Einstein College of Medicine | |
| Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 | NCT01621217 | Locally Advance... | Cetuximab Mitomycin C 5-Fluoruracil Radiotherapy | 18 Years - | Lund University Hospital | |
| Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | NCT00023868 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen cisplatin doxorubicin hyd... fluorouracil irinotecan hydr... leucovorin calc... mitomycin C | 18 Years - 120 Years | American College of Radiology Imaging Network | |
| Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer | NCT01200992 | Bladder Neoplas... Neoplasm Recurr... Transitional Ce... Carcinoma in Si... Mycobacterium | EN3348 Mitomycin C | 18 Years - | Bioniche Life Sciences Inc. | |
| Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer | NCT00318643 | Bladder Cancer | Mitomycin C Chemophase | 18 Years - | Halozyme Therapeutics | |
| Individualized Drug Treatment for Treating Patients With Pancreatic Cancer | NCT00276744 | Pancreatic Canc... | cetuximab capecitabine docetaxel Erlotinib Gemcitabine Irinotecan mitomycin C rapamycin conventional su... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery | NCT00652860 | Metastatic Canc... Sarcoma | aerosol sargram... sargramostim cisplatin doxorubicin hyd... ifosfamide mitomycin C flow cytometry immunological d... laboratory biom... adjuvant therap... multimodality t... neoadjuvant the... therapeutic con... intraoperative ... selective exter... | 18 Years - | Mayo Clinic | |
| Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | NCT00423293 | Anal Cancer | fluorouracil mitomycin C Intensity-modul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | NCT02369939 | Anal Carcinoma | Irradiation Mitomycin C 5-Fluorouracil Hyperthermia | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | NCT01167725 | Colorectal Canc... | bevacizumab cetuximab FOLFIRI regimen FOLFOX regimen capecitabine fluorouracil irinotecan hydr... leucovorin calc... mitomycin C oxaliplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00004209 | Lung Cancer | cisplatin mitomycin C vinblastine sul... | 18 Years - | National Cancer Institute (NCI) | |
| Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer | NCT00384891 | Urinary Bladder... Urinary Bladder... Urinary Bladder... Malignant Tumor... Urologic Diseas... Urologic Neopla... Neoplasms Neoplasms by Si... | Synergo + MMC Bacillus Calmet... | 18 Years - | Medical Enterprises Europe B.V. | |
| Individualized Drug Treatment for Treating Patients With Pancreatic Cancer | NCT00276744 | Pancreatic Canc... | cetuximab capecitabine docetaxel Erlotinib Gemcitabine Irinotecan mitomycin C rapamycin conventional su... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | NCT02369939 | Anal Carcinoma | Irradiation Mitomycin C 5-Fluorouracil Hyperthermia | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia | NCT02199327 | Conjunctival In... Corneal Intraep... | Mitomycin C Interferon Alfa... | 18 Years - 90 Years | Coordinación de Investigación en Salud, Mexico | |
| Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00005825 | Lung Cancer | cisplatin mitomycin C tretinoin vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer | NCT00024271 | Malignant Mesot... | recombinant int... cisplatin doxorubicin hyd... gemcitabine hyd... mitomycin C conventional su... hyperthermia tr... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer | NCT02299999 | Metastatic Brea... | AZD2014 AZD4547 AZD5363 AZD8931 Selumetinib Vandetanib Bicalutamide Olaparib Anthracyclines Taxanes cyclophosphamid... DNA intercalato... Methotrexate vinca alkaloids Platinum based ... Bevacizumab Mitomycin C Eribulin MEDI4736 | 18 Years - | UNICANCER | |
| Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus | NCT00002993 | Sarcoma | cisplatin doxorubicin hyd... mitomycin C | - | GOG Foundation | |
| A Study of Mitomycin C, Irinotecan, and Cetuximab | NCT00271011 | Colorectal Canc... | Mitomycin C Cetuximab Irinotecan. | 18 Years - | University of Michigan Rogel Cancer Center | |
| Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC | NCT03348969 | Bladder Cancer | Mitomycin c | 18 Years - | Aarhus University Hospital | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | NCT00003596 | Anal Cancer | cisplatin fluorouracil mitomycin C radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer | NCT03381352 | Anal Cancer | Chemo-radiother... Capecitabine Mitomycin C | 18 Years - 70 Years | ChineseAMS | |
| BCG With or Without Mitomycin in Treating Patients With Bladder Cancer | NCT00023842 | Bladder Cancer | BCG vaccine mitomycin C adjuvant therap... conventional su... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer | NCT00005944 | Colorectal Canc... Metastatic Canc... Primary Periton... | chemotherapy fluorouracil leucovorin calc... mitomycin C conventional su... laparoscopic su... | 0 Years - 70 Years | UNICANCER | |
| Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers | NCT03604653 | Stomach Cancer Colorectal Canc... Appendiceal Can... Ovarian Cancer Uterine Cancer Cervical Cancer Fallopian Tube ... Primary Periton... | HIPEC Mitomycin c CDDP 50 CDDP 75 Doxorubicin | 18 Years - | Holy Name Medical Center, Inc. | |
| Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer | NCT00002490 | Bladder Cancer | BCG vaccine mitomycin C radiation thera... | - | National Cancer Institute (NCI) | |
| S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer | NCT00003018 | Pancreatic Canc... | dipyridamole fluorouracil leucovorin calc... mitomycin C | 18 Years - | SWOG Cancer Research Network | |
| The Bladder Instillation Comparison Study | NCT02695771 | Urinary Bladder... | Mitomycin C Gemcitabine | 18 Years - | Spectrum Health Hospitals | |
| Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer | NCT01042041 | Hepatocellular ... Liver Cancer Localized Unres... | sorafenib tosyl... doxorubicin hyd... cisplatin mitomycin C transarterial c... hepatic artery ... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | NCT02311101 | Urinary Bladder... | Mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus | NCT00033644 | Sarcoma | sargramostim cisplatin dacarbazine doxorubicin hyd... mitomycin C | 18 Years - | GOG Foundation | |
| Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) | NCT00289445 | Gastrointestina... Neoplasm Metast... | Mitomycin C 5-FU Folinic acid | 18 Years - 75 Years | University Hospital Tuebingen | |
| Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization | NCT00630240 | Hepatocellular ... | 20 Years - 80 Years | Kaohsiung Medical University Chung-Ho Memorial Hospital | ||
| Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | NCT02369939 | Anal Carcinoma | Irradiation Mitomycin C 5-Fluorouracil Hyperthermia | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | NCT00068744 | Anal Cancer | cisplatin fluorouracil mitomycin C radiation thera... | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer | NCT00318643 | Bladder Cancer | Mitomycin C Chemophase | 18 Years - | Halozyme Therapeutics | |
| Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer | NCT01200992 | Bladder Neoplas... Neoplasm Recurr... Transitional Ce... Carcinoma in Si... Mycobacterium | EN3348 Mitomycin C | 18 Years - | Bioniche Life Sciences Inc. | |
| Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer | NCT00003159 | Lung Cancer | carboplatin cisplatin docetaxel gemcitabine hyd... ifosfamide mitomycin C paclitaxel vinblastine sul... vinorelbine tar... conventional su... neoadjuvant the... | - | National Cancer Institute (NCI) | |
| Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | NCT02311101 | Urinary Bladder... | Mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma | NCT01327521 | Carcinoma, Hepa... | CyberKnife TACE CT Contrast doxorubicin Epirubicin 5-fluorouracil Mitomycin C Gemcitabine Cisplatin SMANCS | 18 Years - | Stanford University | |
| Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | NCT01011010 | Liver Cancer | doxorubicin hyd... mitomycin C sorafenib tosyl... laboratory biom... pharmacological... | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | NCT02311101 | Urinary Bladder... | Mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT03330028 | Diseases of Oes... | Dexamethasone Diphenhydramine Famotidine Mitomycin C Cisplatin Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis | NCT03073694 | Cancer, Appendi... ColoRectal Canc... | Mitomycin c Melphalan | 18 Years - 75 Years | University of Kansas Medical Center | |
| Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis | NCT03073694 | Cancer, Appendi... ColoRectal Canc... | Mitomycin c Melphalan | 18 Years - 75 Years | University of Kansas Medical Center | |
| Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma | NCT00075699 | Malignant Mesot... | cisplatin mitomycin C vincristine sul... vinorelbine tar... pain therapy psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer | NCT03664869 | Bladder Cancer | BCG instillatio... Sequential BCG ... | 18 Years - | Turku University Hospital | |
| Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma | NCT05979909 | Urothelial Carc... Urothelial Canc... | Mitomycin C | 18 Years - | McMaster University | |
| Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUC | NCT05731622 | Upper Urinary T... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | ||
| Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | NCT00003596 | Anal Cancer | cisplatin fluorouracil mitomycin C radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | NCT02040142 | Peritoneal Carc... Colorectal Canc... Appendiceal Can... Peritoneal Meso... Pseudomyxoma Pe... Gastric Cancer | HIPEC Mitomycin C | 18 Years - | Albert Einstein College of Medicine | |
| REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation | NCT05902533 | Anal Cancer | Radiation (redu... Capecitabine Mitomycin c | 18 Years - | University of Cincinnati | |
| Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction | NCT01042782 | Advanced Gastri... Advanced Cancer... | RAD001 and Mito... | 18 Years - | Krankenhaus Nordwest | |
| A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) | NCT01799499 | Non Muscle Inva... | TC-3 hydrogel TC-3 hydrogel TC-3 hydrogel | 21 Years - | UroGen Pharma Ltd. | |
| BCG With or Without Mitomycin in Treating Patients With Bladder Cancer | NCT00023842 | Bladder Cancer | BCG vaccine mitomycin C adjuvant therap... conventional su... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study | NCT02793128 | Carcinoma, Tran... Transitional Ce... | UGN-101 instill... | 18 Years - | UroGen Pharma Ltd. | |
| Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors | NCT00003710 | Unspecified Adu... | irinotecan hydr... mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer | NCT00192049 | Superficial Bla... | Gemcitabine mitomycin C | 18 Years - | Eli Lilly and Company | |
| Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer | NCT00201747 | Esophageal Canc... Esophagus Cance... Cancer of Stoma... Stomach Cancer | CPT-11 Mitomycin C | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| The Bladder Instillation Comparison Study | NCT02695771 | Urinary Bladder... | Mitomycin C Gemcitabine | 18 Years - | Spectrum Health Hospitals | |
| Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer | NCT00042887 | Bladder Cancer | mitomycin C conventional su... | - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Therapeutic Instillation of Mistletoe | NCT02106572 | Superficial Bla... | abnobaVISCUM 90... Mitomycin C | 18 Years - 85 Years | Abnoba Gmbh | |
| Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer | NCT00734994 | Transitional Ce... Superficial Bla... | Hyperthermia Sy... Mitomycin C | 18 Years - 75 Years | Duke University | |
| Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | NCT00003240 | Lung Cancer | cisplatin ifosfamide mitomycin C vinblastine sul... vindesine vinorelbine tar... conventional su... radiation thera... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
